Cully, Switzerland

Gérard Masson


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gérard Masson: Innovator in Nutritional Solutions for PKU Patients

Introduction

Gérard Masson is a notable inventor based in Cully, Switzerland. He has made significant contributions to the field of nutrition, particularly for patients suffering from phenylketonuria (PKU). His innovative approach has led to the development of a specialized nutritional formula that addresses the unique dietary needs of these patients.

Latest Patents

Gérard Masson holds a patent for a nutritional formula specifically designed for PKU patients. This formula utilizes a mixture of caseino-glyco-macropeptide and complementary essential amino acids, excluding phenylalanine (Phe), to create a balanced amino acid profile. The formula also includes essential vitamins and minerals to meet daily nutritional requirements. When used as a complete diet, it incorporates both carbohydrate and fat sources, although it can also serve as a protein supplement without these additional components. Notably, the nutritional formula is designed to have a pleasant taste, making it more appealing for patients.

Career Highlights

Gérard Masson is associated with Nestec S.A., a company known for its commitment to nutritional science and innovation. His work at Nestec has allowed him to focus on developing solutions that improve the quality of life for individuals with specific dietary restrictions.

Collaborations

Throughout his career, Gérard has collaborated with esteemed colleagues such as Julio Cesar Monti and Olivier Ballevre. These partnerships have fostered a collaborative environment that enhances the development of innovative nutritional solutions.

Conclusion

Gérard Masson is a pioneering inventor whose work in creating a nutritional formula for PKU patients exemplifies the intersection of science and compassion. His contributions continue to make a positive impact on the lives of those affected by this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…